The Discounted Cash Flow (DCF) valuation of Jagson Pal Pharmaceuticals Ltd (JAGSNPHARM.NS) is 118.47 INR. With the latest stock price at 242.09 INR, the upside of Jagson Pal Pharmaceuticals Ltd based on DCF is -51.1%.
Based on the latest price of 242.09 INR and our DCF valuation, Jagson Pal Pharmaceuticals Ltd (JAGSNPHARM.NS) is a sell. selling JAGSNPHARM.NS stocks now will result in a potential gain of 51.1%.
| Range | Selected | |
| WACC / Discount Rate | 13.1% - 15.4% | 14.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 100.85 - 145.28 | 118.47 |
| Upside | -58.3% - -40.0% | -51.1% |